Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Improved glycemic control through enhanced glucose-dependent insulin secretion and reduced glucagon secretion [3]
SLURP-2, a novel member of the human Ly-6 superfamily that is up-regulated in psoriasis vulgaris
To view or add a comment, sign in Insulin Pharmacotherapy Across the Continuum of Care: Indications, Mechanisms, Adverse Effects, and Management ---- --- Dr Indunil Karunarathna Uva Clinical Research Lab 2026 Uva Clinical Anaesthesia and Intensive Care ISSN 2827-7198, 2026 Insulin remains an indispensable biologic agent in modern therapeutics, with its most critical applications centered on type 1 diabetes mellitus, advanced type 2 diabetes mellitus, gestational diabetes, and acute metabolic emergencies such as diabetic ketoacidosis and the hyperosmolar hyperglycemic state
Medicaid coverage depends on your state
Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trial
Management of hyperglycemia associated with pasireotide (SOM230): healthy volunteer study
US$ 27.05
US$ 29.18
US$ 26.92
US$ 28.86
US$ 22.57
US$ 29.40
US$ 29.03
